Literature DB >> 22209388

Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes.

Michael Kidorf1, Van L King, Neeraj Gandotra, Ken Kolodner, Robert K Brooner.   

Abstract

BACKGROUND: Developing bridges between community syringe exchange programs (SEPs) and substance abuse treatment could benefit syringe exchangers and the public health. Kidorf et al. (2009) showed that motivational approaches employed at an SEP site improved rates of treatment enrollment and reduced drug use over a 4-month observation window. The present study extends this report by evaluating rates of treatment enrollment and re-enrollment over a 12-month period.
METHODS: Opioid dependent individuals (n = 281) newly registered at an SEP were randomly assigned to one of three referral interventions: (1) 8 individual motivational enhancement sessions and 16 treatment readiness group sessions designed to improve treatment interest and readiness (motivated referral condition; MRC-only); (2) MRC-only with monetary incentives for attending sessions and enrolling in treatment (MRC+I); or (3) standard referral (SRC). MRC-only and MRC+I participants discharged from treatment could attend a treatment re-engagement group designed to facilitate return to treatment (MRC+I participants received incentives for attending sessions and re-enrolling in treatment).
RESULTS: The 4-month outcomes generally extended over 12 months. MRC+I participants were more likely to enroll in methadone maintenance than MRC-only or SRC participants, and to re-enroll in treatment following discharge. MRC+I participants also reported more days of treatment and less heroin and injection use.
CONCLUSIONS: The good harm reduction outcomes for many SEP participants can be enhanced through strategies designed to facilitate treatment enrollment and re-enrollment.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22209388      PMCID: PMC3341500          DOI: 10.1016/j.drugalcdep.2011.12.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  22 in total

Review 1.  Drug abuse treatment as an HIV prevention strategy: a review.

Authors:  J L Sorensen; A L Copeland
Journal:  Drug Alcohol Depend       Date:  2000-04-01       Impact factor: 4.492

Review 2.  Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.

Authors:  Alex Wodak; Annie Cooney
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

Review 3.  Expanding the public health benefits of syringe exchange programs.

Authors:  Michael Kidorf; Van L King
Journal:  Can J Psychiatry       Date:  2008-08       Impact factor: 4.356

4.  Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Authors:  James L Sorensen; Nancy A Haug; Kevin L Delucchi; Valerie Gruber; Evan Kletter; Steven L Batki; Jacqueline P Tulsky; Paul Barnett; Sharon Hall
Journal:  Drug Alcohol Depend       Date:  2006-10-23       Impact factor: 4.492

5.  Benefits of concurrent syringe exchange and substance abuse treatment participation.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Jessica Pierce; Ken Kolodner; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2011-01-20

6.  Doing harm reduction better: syringe exchange in the United States.

Authors:  Don C Des Jarlais; Courtney McKnight; Cullen Goldblatt; David Purchase
Journal:  Addiction       Date:  2009-02-10       Impact factor: 6.526

7.  A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals.

Authors:  Karin Neufeld; Van King; Jessica Peirce; Ken Kolodner; Robert Brooner; Michael Kidorf
Journal:  Drug Alcohol Depend       Date:  2008-05-16       Impact factor: 4.492

8.  Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.

Authors:  Don C Des Jarlais; Naomi Braine; Huso Yi; Charles Turner
Journal:  AIDS Educ Prev       Date:  2007-04

9.  Improving substance abuse treatment enrollment in community syringe exchangers.

Authors:  Michael Kidorf; Van L King; Karin Neufeld; Jessica Peirce; Ken Kolodner; Robert K Brooner
Journal:  Addiction       Date:  2009-05       Impact factor: 6.526

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  6 in total

1.  The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Authors:  August F Holtyn; Mikhail N Koffarnus; Anthony DeFulio; Sigurdur O Sigurdsson; Eric C Strain; Robert P Schwartz; Jeannie-Marie S Leoutsakos; Kenneth Silverman
Journal:  Prev Med       Date:  2014-03-04       Impact factor: 4.018

2.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

3.  Prospective risk factors for traumatic event reexposure in community syringe exchange participants.

Authors:  Jessica M Peirce; Rebecca L Schacht; Robert K Brooner; Van L King; Michael S Kidorf
Journal:  Drug Alcohol Depend       Date:  2014-02-20       Impact factor: 4.492

Review 4.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

5.  Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.

Authors:  Dennis P Watson; James A Swartz; Lisa Robison-Taylor; Mary Ellen Mackesy-Amiti; Kim Erwin; Nicole Gastala; Antonio D Jimenez; Monte D Staton; Sarah Messmer
Journal:  BMC Public Health       Date:  2021-03-31       Impact factor: 3.295

Review 6.  Misalignment of Stakeholder Incentives in the Opioid Crisis.

Authors:  Alireza Boloori; Bengt B Arnetz; Frederi Viens; Taps Maiti; Judith E Arnetz
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.